ADA and ocular melanoma: Forward MR analysis revealed that higher genetically predicted levels of ADA and osteoprotegerin (also known as tumor necrosis factor receptor superfamily member 11B; OPG) were associated with reduced OM risk, suggesting protective roles, whereas increased levels of LTA were linked to higher susceptibility.